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INTRODUCTION: Idiopathic Juvenile Osteoporosis is an uncommon condition that has few case reports
in the literature. Reported series indicate that it is a condition classically accompanying vertebral and
metaphyseal fractures during the immediate pre-puberty years but that seems to develop naturally dur-
ing puberty. Current clinical treatment is complicated because of lack of understanding on the origins of
Idiopathic Juvenile Osteoporosis.
PRESENTATION OF CASE: The 13-year-old female patient with no former complaints had pain in her left
hip while walking 2 years ago. Excluding the secondary osteoporosis reasons, the patient was diagnosed
with Idiopathic Juvenile Osteoporosis and after the medical treatment she was followed-up.
DISCUSSION: The patient was subjected to a rehabilitation program for muscle weakness. She had difﬁ-
culty in walking as a result of prolonged immobilization. At the end of a two-year treatment, signiﬁcant
improvement was achieved in muscle strength in the extremities, walking distance, and posture.
CONCLUSION:With this report,wewould like to raise awareness about a possible association of persistent
fractures with this rare metabolic disorder, Idiopathic Juvenile Osteoporosis, which should be included
in differential diagnosis of patients with persistent appendicular skeleton fractures.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Idiopathic JuvenileOsteoporosis is a sporadic disease of children
manifesting between the 2nd and 14th years of life with pain in
bones, fractures and deformity of the axial and appendicular as a
part of clinical evaluation skeleton after minimal traumas [1]. It
is important to differentiate the diagnosis for conditions causing
generalized osteoporosis in childhood. It is diagnosed by excluding
the other causes [2–6].
The purpose of this study is to evaluate the clinical symptoms of
a patient diagnosed with Idiopathic Juvenile Osteoporosis by using
radiographic and biochemical examinations.
2. Presentation of case
The 13-year-old female patient with no former complaints had
pain in her left hip while walking 2 years ago. After left femoral
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neck fracture was detected in the patient with no trauma his-
tory, she was given surgical treatment in the orthopedic clinic.
She was sent to our hospital because of a 2 years’ history of back
pain, knee pain, feet pain and difﬁculty in walking. She was given
conservative treatment because of radius distal fracture, humerus
proximal and diaphysis fracture which developed without trauma
(Figs. 1 and 2). Therewas no associationwith a traumaor additional
diseases. Examination results of the other systems were normal.
There was no family history of frequent fractures, childhood or
adolescent osteoporosis, osteogenesis imperfecta, gross skeletal
anomalies, rickets, discolored sclera, or early onset of hearing
loss.
The pubertal development was as in Tanner Stage 2. The scle-
rae were white and the teeth were unaffected. The hearing of
the patient was normal. Her Body Mass Index was 22.6 kg/m2.
Complete blood cell count and electrolytes were normal. Serum
calcium (8.7mg/dL), phosphorus (4.6mg/dL), bone alkaline phos-
phatase 420 IU/L (normal <345 IU/L), blood urea (6mg/dL), serum
creatinine (0.5mg/dL), urine pH (6,2), and blood gases were
within normal ranges. Parameters of liver function, creatine
kinase, serum protein electrophoresis, rheumatological tests, glu-
cose, and erythrocyte sedimentation were all in the appropriate
reference ranges. Twenty-four-hour urinary calcium excretion
was normal. There were no proteinuria or aminoaciduria. Serum
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Fig. 1. Demonstrating the long thin diaphyses and the widespread disorganized
metaphyses. The appearances on the right were almost identical (black arrows).
Fig. 2. Right radius distal angulation deformity (black arrow).
ceruloplasmin (15mg/dL) and copper values (78g/dL) were
also normal. The use of any medications known to affect the
bone metabolism, including glucocorticoids, heparin, cyclosporine,
GnRH agonist, l-thyroxin, methotrexate was excluded. The thyroid
function test, parathyroid functions, somatomedin C, follicu-
lar stimulating hormone, luteinizing hormone, estradiol, plasma
cortisol and urinary cortisol were normal. The bone density exami-
nation of the skeleton was carried out with dual-emission X-ray
absorptiometry based on the pediatric program, which includes
international reference values for children. The bone mineral den-
sity of the lumbar vertebra (L1–L4) was assessed in the “hip” and
“spine” programs. The Spine Z-score was −2.63, the Hip Z-score
was −2,04. Transiliac bone biopsy was carried out in our patient
to exclude systemic disease. The histomorphometric parameters of
the skeletonwere not determined. However, consent to skin biopsy
for collagen analysis, and no disorder of collagen synthesis was
found. Extensive radiologic and biochemical tests were performed
to exclude secondary osteoporosis. The patientwas diagnosedwith
Idiopathic Juvenile Osteoporosis.
Differential diagnosis:
• osteogenesis imperfecta,
• rickets,
• Turner’s syndrome,
• malabsorption syndrome,
• Wilson’s disease,
• Osteoporosis,
• pseudoglioma syndrome,
• homocystinuria,
• acquired disorders such as celiac disease, medical diseases
(hypothyroidism, diabetes mellitus, malabsorption disorders,
anorexia nervosa, etc.),
• immobilization,
• malignancy,
• glucocorticoids [2–6].
The patient was given a treatment which included alendronate
35mg/week, supplemental calcium (2000mg/day) and vitamin D
(400 IU/day). Since she developed spontaneous fracture despite
the treatment for 6 months and her Z-score of the Bone Mineral
Density was (L1–L4): −2.94, the treatment protocol was revised.
The former treatment was terminated and a new one was started
including 0.5mg/kg/day pamidronate for 2 days every 3 months,
calcitonin 2/week 200Ü, calcitriol 2/week 0.25mcg. Following the
2-year treatment Z- scores were normalized.
The patient, who had sustained immobilization due to multiple
fractures and fear to fall, was subjected to rehabilitation program
after she developed difﬁculty to walk, ﬂexion posture in the body,
limitation in joint mobility clearance and weakness in lower and
upper extremity muscles.
She received programs including strengthening in joint mobil-
ity clearance in extremities, back muscles, and posture exercise
and walking training. At the end of 2-year treatment, signiﬁcant
improvementswere observed inwalkingdistance, lower andupper
extremity muscle strengths and posture.
3. Discussion
Idiopathic Juvenile Osteoporosis was ﬁrst described by Schip-
pers in 1938 [1]. Once all of the known causes of decreased bone
mass are excluded, there remains one formof osteoporosis over IJO,
which was ﬁrst recognized by Dent in 1965 [1,7]. Due to the rare
prevalence of Idiopathic Juvenile Osteoporosis, only approximately
100 cases have been reported in the literature, and its descriptions
have been limited to case reports [1].
Idiopathic Juvenile Osteoporosis is characterized with a 2-fold
dysfunction of cancellous bone formation. First, fewer remodeling
cycles are initiated. This will not be detrimental to bone integrity
in the short run, as the recruitment of osteoblast and osteoclast
teams are similarly decreased. Second, the amount of bone formed
in each remodeling cycle is decreased. The consequences are the
thinning of mature trabeculae and possibly decreased production
of secondary trabeculae in the metaphyses [8].
No heritable genetic mutations have been identiﬁed in patients
with IJO and absence of family members with a history of pedi-
atric or adolescent osteoporosis suggests IJO [9–11]. Autosomal
recessive inheritance has been suggested by Hou and Wang [12];
unfortunately, they did not elaborate on this suggestion nor offer
any speciﬁc scientiﬁc support [4].
In the present case, we excluded rickets by normal values of
serum calcium, phosphorus, alkaline phosphatase, and absence of
characteristic radiological changes. Endocrinal causes were ruled
out by hormonal assays. Normal levels of serum urea, serum cre-
atinine, blood gases and urine pH excluded renal and metabolic
causes. Wilson’s disease was made unlikely by normal cerulo-
plasmin and copper values. Normal eye examination ruled out
osteoporosispseudogliomasyndrome, another rare conditioncaus-
ing generalized osteoporosis. After excluding these conditions, we
considered two primary demineralization disorders occurring in
the childhood as Osteogenesis Imperfecta and Idiopathic Juvenile
Osteoporosis. The differentiation between osteogenesis imperfecta
and Idiopathic Juvenile Osteoporosis may be difﬁcult, especially
in milder cases [9,13]. Extra-skeletal manifestations, including
those which are typical for osteogenesis imperfecta (blue scle-
rae, dentinogenesis imperfecta, joint hyperlaxity, deafness, cardiac
lesions), were absent [5,13].
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Osteogenesis imperfecta is a group of genetically inherited dis-
orders characterized by bone fragility. All forms of osteogenesis
imperfecta involve a structural defect in the production of Type I
collagen [4,13]. Thus, with this clinical exercise along with relevant
investigations to excludemany other conditionswith osteoporosis,
we arrived at a diagnosis of Idiopathic Juvenile Osteoporosis. 25 OH
D3 vitamin levels were not measured in our study and this was a
limitation.
Current treatment of patients with Idiopathic Juvenile Osteo-
porosis is limited to bisphosphonate therapy, calcium, and vitamin
D supplementation. Limited physical activity will assist in limiting
fragility fractures. Furthermore, studies are indicated in the quest
to seek the etiology of Idiopathic Juvenile Osteoporosis [1,4,14].
Further research is needed to learn whether the Idiopathic Juvenile
Osteoporosis was recovered with the treatment given, or it was a
self-limiting disease.
4. Conclusion
Important clues which guided us to the diagnosis of Idiopathic
Juvenile Osteoporosis were:
• Absence of family history of pediatric or adolescent osteoporosis.
• Presence of osseous osteoporosis on radiography.
• Absence of collagen defect on skin biopsy.
• No other identiﬁable causes of bone loss.
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